Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PT001 (Glycopyrronium) in Persistent Asthma
NCT03358147Phase 3Completed
- Sponsor
- Pearl Therapeutics
- Start
- Dec 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of glycopyrronium in asthma, sponsored by Pearl Therapeutics. Started Dec 2017; status: completed.
02
Drugs
glycopyrronium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03358147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03358147.